Trials / Conditions / Unresectable Bladder Urothelial Carcinoma
Unresectable Bladder Urothelial Carcinoma
3 registered clinical trials studyying Unresectable Bladder Urothelial Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | ARID1A and/or KDM6A Mutation and CXCL13 Expression NCT04953104 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial C NCT03513952 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metasta NCT03237780 | National Cancer Institute (NCI) | Phase 2 |